aluates Reports

$ 0.0

Automative

Global Geographic Atrophy Treatment Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-26L9978

Global Geographic Atrophy Treatment Market Research Report 2022

BUY CHAPTERS

Global Geographic Atrophy Treatment Market Research Report 2025

Code: QYRE-Auto-26L9978

Report

March 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Apellis Pharmaceuticals

IVERIC bio

Alkeus Pharmaceuticals

Hemera Biosciences

Allegro Ophthalmics

Stealth Biotherapeutics

Gyroscope Therapeutics

Regenerative Patch Technologies

Roche Holding AG

GenSight Biologics SA

NGM Biopharmaceuticals

Astrazeneca plc

Lineage Cell Therapeutics

Allergan plc

Geographic Atrophy Treatment Market Size

The global market for Geographic Atrophy Treatment was valued at US$ 5809 million in the year 2024 and is projected to reach a revised size of US$ 7665 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Geographic Atrophy Treatment Market

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Geographic Atrophy Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geographic Atrophy Treatment.

The Geographic Atrophy Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Geographic Atrophy Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Geographic Atrophy Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Geographic Atrophy Treatment Market Report

Report Metric	Details
Report Name	Geographic Atrophy Treatment Market
Accounted market size in year	US$ 5809 million
Forecasted market size in 2031	US$ 7665 million
CAGR	4.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Late-stage (Phase III) Treatment Phase II Treatment Phase I Treatment Pre-Clinical Stage Treatment
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Apellis Pharmaceuticals, IVERIC bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies, Roche Holding AG, Gensight Biologics SA, NGM Biopharmaceuticals, AstraZeneca, Lineage Cell Therapeutics, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geographic Atrophy Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Geographic Atrophy Treatment Market growing?

Ans: The Geographic Atrophy Treatment Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Geographic Atrophy Treatment Market size in 2031?

Ans: The Geographic Atrophy Treatment Market size in 2031 will be US$ 7665 million.

Who are the main players in the Geographic Atrophy Treatment Market report?

Ans: The main players in the Geographic Atrophy Treatment Market are Apellis Pharmaceuticals, IVERIC bio, Alkeus Pharmaceuticals, Hemera Biosciences, Allegro Ophthalmics, Stealth BioTherapeutics, Gyroscope Therapeutics, Regenerative Patch Technologies, Roche Holding AG, Gensight Biologics SA, NGM Biopharmaceuticals, AstraZeneca, Lineage Cell Therapeutics, Allergan

What are the Application segmentation covered in the Geographic Atrophy Treatment Market report?

Ans: The Applications covered in the Geographic Atrophy Treatment Market report are Hospital, Clinic

What are the Type segmentation covered in the Geographic Atrophy Treatment Market report?

Ans: The Types covered in the Geographic Atrophy Treatment Market report are Late-stage (Phase III) Treatment, Phase II Treatment, Phase I Treatment, Pre-Clinical Stage Treatment

Recommended Reports

Eye Disease Treatments

Neurodegenerative Diseases

Rare And Genetic Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Geographic Atrophy Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Late-stage (Phase III) Treatment

1.2.3 Phase II Treatment

1.2.4 Phase I Treatment

1.2.5 Pre-Clinical Stage Treatment

1.3 Market by Application

1.3.1 Global Geographic Atrophy Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Geographic Atrophy Treatment Market Perspective (2020-2031)

2.2 Global Geographic Atrophy Treatment Growth Trends by Region

2.2.1 Global Geographic Atrophy Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Geographic Atrophy Treatment Historic Market Size by Region (2020-2025)

2.2.3 Geographic Atrophy Treatment Forecasted Market Size by Region (2026-2031)

2.3 Geographic Atrophy Treatment Market Dynamics

2.3.1 Geographic Atrophy Treatment Industry Trends

2.3.2 Geographic Atrophy Treatment Market Drivers

2.3.3 Geographic Atrophy Treatment Market Challenges

2.3.4 Geographic Atrophy Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Geographic Atrophy Treatment Players by Revenue

3.1.1 Global Top Geographic Atrophy Treatment Players by Revenue (2020-2025)

3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Geographic Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Geographic Atrophy Treatment Revenue

3.4 Global Geographic Atrophy Treatment Market Concentration Ratio

3.4.1 Global Geographic Atrophy Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Treatment Revenue in 2024

3.5 Global Key Players of Geographic Atrophy Treatment Head office and Area Served

3.6 Global Key Players of Geographic Atrophy Treatment, Product and Application

3.7 Global Key Players of Geographic Atrophy Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Geographic Atrophy Treatment Breakdown Data by Type

4.1 Global Geographic Atrophy Treatment Historic Market Size by Type (2020-2025)

4.2 Global Geographic Atrophy Treatment Forecasted Market Size by Type (2026-2031)

5 Geographic Atrophy Treatment Breakdown Data by Application

5.1 Global Geographic Atrophy Treatment Historic Market Size by Application (2020-2025)

5.2 Global Geographic Atrophy Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Geographic Atrophy Treatment Market Size (2020-2031)

6.2 North America Geographic Atrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Geographic Atrophy Treatment Market Size by Country (2020-2025)

6.4 North America Geographic Atrophy Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Geographic Atrophy Treatment Market Size (2020-2031)

7.2 Europe Geographic Atrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Geographic Atrophy Treatment Market Size by Country (2020-2025)

7.4 Europe Geographic Atrophy Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Geographic Atrophy Treatment Market Size (2020-2031)

8.2 Asia-Pacific Geographic Atrophy Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Geographic Atrophy Treatment Market Size (2020-2031)

9.2 Latin America Geographic Atrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Geographic Atrophy Treatment Market Size by Country (2020-2025)

9.4 Latin America Geographic Atrophy Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Geographic Atrophy Treatment Market Size (2020-2031)

10.2 Middle East & Africa Geographic Atrophy Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Apellis Pharmaceuticals

11.1.1 Apellis Pharmaceuticals Company Details

11.1.2 Apellis Pharmaceuticals Business Overview

11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Introduction

11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.1.5 Apellis Pharmaceuticals Recent Development

11.2 IVERIC bio

11.2.1 IVERIC bio Company Details

11.2.2 IVERIC bio Business Overview

11.2.3 IVERIC bio Geographic Atrophy Treatment Introduction

11.2.4 IVERIC bio Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.2.5 IVERIC bio Recent Development

11.3 Alkeus Pharmaceuticals

11.3.1 Alkeus Pharmaceuticals Company Details

11.3.2 Alkeus Pharmaceuticals Business Overview

11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Introduction

11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.3.5 Alkeus Pharmaceuticals Recent Development

11.4 Hemera Biosciences

11.4.1 Hemera Biosciences Company Details

11.4.2 Hemera Biosciences Business Overview

11.4.3 Hemera Biosciences Geographic Atrophy Treatment Introduction

11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.4.5 Hemera Biosciences Recent Development

11.5 Allegro Ophthalmics

11.5.1 Allegro Ophthalmics Company Details

11.5.2 Allegro Ophthalmics Business Overview

11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Introduction

11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.5.5 Allegro Ophthalmics Recent Development

11.6 Stealth BioTherapeutics

11.6.1 Stealth BioTherapeutics Company Details

11.6.2 Stealth BioTherapeutics Business Overview

11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Introduction

11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.6.5 Stealth BioTherapeutics Recent Development

11.7 Gyroscope Therapeutics

11.7.1 Gyroscope Therapeutics Company Details

11.7.2 Gyroscope Therapeutics Business Overview

11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Introduction

11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.7.5 Gyroscope Therapeutics Recent Development

11.8 Regenerative Patch Technologies

11.8.1 Regenerative Patch Technologies Company Details

11.8.2 Regenerative Patch Technologies Business Overview

11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Introduction

11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.8.5 Regenerative Patch Technologies Recent Development

11.9 Roche Holding AG

11.9.1 Roche Holding AG Company Details

11.9.2 Roche Holding AG Business Overview

11.9.3 Roche Holding AG Geographic Atrophy Treatment Introduction

11.9.4 Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.9.5 Roche Holding AG Recent Development

11.10 Gensight Biologics SA

11.10.1 Gensight Biologics SA Company Details

11.10.2 Gensight Biologics SA Business Overview

11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Introduction

11.10.4 Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.10.5 Gensight Biologics SA Recent Development

11.11 NGM Biopharmaceuticals

11.11.1 NGM Biopharmaceuticals Company Details

11.11.2 NGM Biopharmaceuticals Business Overview

11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Introduction

11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.11.5 NGM Biopharmaceuticals Recent Development

11.12 AstraZeneca

11.12.1 AstraZeneca Company Details

11.12.2 AstraZeneca Business Overview

11.12.3 AstraZeneca Geographic Atrophy Treatment Introduction

11.12.4 AstraZeneca Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.12.5 AstraZeneca Recent Development

11.13 Lineage Cell Therapeutics

11.13.1 Lineage Cell Therapeutics Company Details

11.13.2 Lineage Cell Therapeutics Business Overview

11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Introduction

11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.13.5 Lineage Cell Therapeutics Recent Development

11.14 Allergan

11.14.1 Allergan Company Details

11.14.2 Allergan Business Overview

11.14.3 Allergan Geographic Atrophy Treatment Introduction

11.14.4 Allergan Revenue in Geographic Atrophy Treatment Business (2020-2025)

11.14.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Apellis Pharmaceuticals

IVERIC bio

Alkeus Pharmaceuticals

Hemera Biosciences

Allegro Ophthalmics

Stealth Biotherapeutics

Gyroscope Therapeutics

Regenerative Patch Technologies

Roche Holding AG

GenSight Biologics SA

NGM Biopharmaceuticals

Astrazeneca plc

Lineage Cell Therapeutics

Allergan plc

List of Tables

Table 1. Global Geographic Atrophy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Late-stage (Phase III) Treatment

Table 3. Key Players of Phase II Treatment

Table 4. Key Players of Phase I Treatment

Table 5. Key Players of Pre-Clinical Stage Treatment

Table 6. Global Geographic Atrophy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Geographic Atrophy Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Geographic Atrophy Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Geographic Atrophy Treatment Market Share by Region (2020-2025)

Table 10. Global Geographic Atrophy Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Geographic Atrophy Treatment Market Share by Region (2026-2031)

Table 12. Geographic Atrophy Treatment Market Trends

Table 13. Geographic Atrophy Treatment Market Drivers

Table 14. Geographic Atrophy Treatment Market Challenges

Table 15. Geographic Atrophy Treatment Market Restraints

Table 16. Global Geographic Atrophy Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Geographic Atrophy Treatment Market Share by Players (2020-2025)

Table 18. Global Top Geographic Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2024)

Table 19. Ranking of Global Top Geographic Atrophy Treatment Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Geographic Atrophy Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Geographic Atrophy Treatment, Headquarters and Area Served

Table 22. Global Key Players of Geographic Atrophy Treatment, Product and Application

Table 23. Global Key Players of Geographic Atrophy Treatment, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Geographic Atrophy Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Geographic Atrophy Treatment Revenue Market Share by Type (2020-2025)

Table 27. Global Geographic Atrophy Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Geographic Atrophy Treatment Revenue Market Share by Type (2026-2031)

Table 29. Global Geographic Atrophy Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Geographic Atrophy Treatment Revenue Market Share by Application (2020-2025)

Table 31. Global Geographic Atrophy Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Geographic Atrophy Treatment Revenue Market Share by Application (2026-2031)

Table 33. North America Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Geographic Atrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Geographic Atrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Geographic Atrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Geographic Atrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Geographic Atrophy Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Geographic Atrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Geographic Atrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Geographic Atrophy Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Apellis Pharmaceuticals Company Details

Table 49. Apellis Pharmaceuticals Business Overview

Table 50. Apellis Pharmaceuticals Geographic Atrophy Treatment Product

Table 51. Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 52. Apellis Pharmaceuticals Recent Development

Table 53. IVERIC bio Company Details

Table 54. IVERIC bio Business Overview

Table 55. IVERIC bio Geographic Atrophy Treatment Product

Table 56. IVERIC bio Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 57. IVERIC bio Recent Development

Table 58. Alkeus Pharmaceuticals Company Details

Table 59. Alkeus Pharmaceuticals Business Overview

Table 60. Alkeus Pharmaceuticals Geographic Atrophy Treatment Product

Table 61. Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 62. Alkeus Pharmaceuticals Recent Development

Table 63. Hemera Biosciences Company Details

Table 64. Hemera Biosciences Business Overview

Table 65. Hemera Biosciences Geographic Atrophy Treatment Product

Table 66. Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 67. Hemera Biosciences Recent Development

Table 68. Allegro Ophthalmics Company Details

Table 69. Allegro Ophthalmics Business Overview

Table 70. Allegro Ophthalmics Geographic Atrophy Treatment Product

Table 71. Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 72. Allegro Ophthalmics Recent Development

Table 73. Stealth BioTherapeutics Company Details

Table 74. Stealth BioTherapeutics Business Overview

Table 75. Stealth BioTherapeutics Geographic Atrophy Treatment Product

Table 76. Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 77. Stealth BioTherapeutics Recent Development

Table 78. Gyroscope Therapeutics Company Details

Table 79. Gyroscope Therapeutics Business Overview

Table 80. Gyroscope Therapeutics Geographic Atrophy Treatment Product

Table 81. Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 82. Gyroscope Therapeutics Recent Development

Table 83. Regenerative Patch Technologies Company Details

Table 84. Regenerative Patch Technologies Business Overview

Table 85. Regenerative Patch Technologies Geographic Atrophy Treatment Product

Table 86. Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 87. Regenerative Patch Technologies Recent Development

Table 88. Roche Holding AG Company Details

Table 89. Roche Holding AG Business Overview

Table 90. Roche Holding AG Geographic Atrophy Treatment Product

Table 91. Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 92. Roche Holding AG Recent Development

Table 93. Gensight Biologics SA Company Details

Table 94. Gensight Biologics SA Business Overview

Table 95. Gensight Biologics SA Geographic Atrophy Treatment Product

Table 96. Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 97. Gensight Biologics SA Recent Development

Table 98. NGM Biopharmaceuticals Company Details

Table 99. NGM Biopharmaceuticals Business Overview

Table 100. NGM Biopharmaceuticals Geographic Atrophy Treatment Product

Table 101. NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 102. NGM Biopharmaceuticals Recent Development

Table 103. AstraZeneca Company Details

Table 104. AstraZeneca Business Overview

Table 105. AstraZeneca Geographic Atrophy Treatment Product

Table 106. AstraZeneca Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 107. AstraZeneca Recent Development

Table 108. Lineage Cell Therapeutics Company Details

Table 109. Lineage Cell Therapeutics Business Overview

Table 110. Lineage Cell Therapeutics Geographic Atrophy Treatment Product

Table 111. Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 112. Lineage Cell Therapeutics Recent Development

Table 113. Allergan Company Details

Table 114. Allergan Business Overview

Table 115. Allergan Geographic Atrophy Treatment Product

Table 116. Allergan Revenue in Geographic Atrophy Treatment Business (2020-2025) & (US$ Million)

Table 117. Allergan Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Geographic Atrophy Treatment Picture

Figure 2. Global Geographic Atrophy Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Geographic Atrophy Treatment Market Share by Type: 2024 VS 2031

Figure 4. Late-stage (Phase III) Treatment Features

Figure 5. Phase II Treatment Features

Figure 6. Phase I Treatment Features

Figure 7. Pre-Clinical Stage Treatment Features

Figure 8. Global Geographic Atrophy Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Geographic Atrophy Treatment Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Clinic Case Studies

Figure 12. Geographic Atrophy Treatment Report Years Considered

Figure 13. Global Geographic Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Geographic Atrophy Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Geographic Atrophy Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Geographic Atrophy Treatment Market Share by Players in 2024

Figure 17. Global Top Geographic Atrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geographic Atrophy Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Geographic Atrophy Treatment Revenue in 2024

Figure 19. North America Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Geographic Atrophy Treatment Market Share by Country (2020-2031)

Figure 21. United States Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Geographic Atrophy Treatment Market Share by Country (2020-2031)

Figure 25. Germany Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Geographic Atrophy Treatment Market Share by Region (2020-2031)

Figure 33. China Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Geographic Atrophy Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Geographic Atrophy Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Geographic Atrophy Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Apellis Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 49. IVERIC bio Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 50. Alkeus Pharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 51. Hemera Biosciences Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 52. Allegro Ophthalmics Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 53. Stealth BioTherapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 54. Gyroscope Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 55. Regenerative Patch Technologies Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 56. Roche Holding AG Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 57. Gensight Biologics SA Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 58. NGM Biopharmaceuticals Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 59. AstraZeneca Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 60. Lineage Cell Therapeutics Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 61. Allergan Revenue Growth Rate in Geographic Atrophy Treatment Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Geographic Atrophy Drugs Market Research Report 2024

Global Macular Degeneration Treatment Market Research Report 2024

Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024

Global Retinitis Pigmentosa Retinitis Market Insights Forecast to 2030

Global Ophthalmology Disorders Drug Market Insights Forecast to 2030

Choroideremia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cone rod Dystrophy Treatment Market Research Report 2025

Global Ophthalmology for Age related Macular Degeneration Diseases Market Research Report 2024

Global Retinal Disorders Treatment Market Research Report 2024

Global Macular Edema and Macular Degeneration Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions